Novonesis: Global uncertainty catalysing increased biosolutions demand
Ester Baiget, CEO of Novonesis discusses Q1 earnings, and explains why the company does not expect a significant impact from the Middle East conflict.
Source: MSN The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments